Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research

Kyle R. Brimacombe(National Institutes of Health), Tongan Zhao(National Institutes of Health), Richard T. Eastman(National Institutes of Health), Xin Hu(National Institutes of Health), Ke Wang(National Institutes of Health), Mark Backus(National Institutes of Health), Bolormaa Baljinnyam(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Lu Chen(National Institutes of Health), Tara Eicher(National Institutes of Health), Marc Ferrer(National Institutes of Health), Ying Fu(National Institutes of Health), Kirill Gorshkov(National Institutes of Health), Hui Guo(National Institutes of Health), Quinlin Hanson(National Institutes of Health), Zina Itkin(National Institutes of Health), Stephen C. Kales(National Institutes of Health), Carleen Klumpp‐Thomas(National Institutes of Health), Emily M. Lee(National Institutes of Health), Sam Michael(National Institutes of Health), Tim Mierzwa(National Institutes of Health), Andrew Patt(National Institutes of Health), Manisha Pradhan(National Institutes of Health), Alex Renn(National Institutes of Health), Paul Shinn(National Institutes of Health), Jonathan H. Shrimp(National Institutes of Health), Amit Viraktamath(National Institutes of Health), Kelli M. Wilson(National Institutes of Health), Miao Xu(National Institutes of Health), Alexey Zakharov(National Institutes of Health), Wei Zhu(National Institutes of Health), Wei Zheng(National Institutes of Health), Anton Simeonov(National Institutes of Health), Ewy A. Mathé(National Institutes of Health), Donald C. Lo(National Institutes of Health), Matthew D. Hall(National Institutes of Health), Min Shen(National Institutes of Health), Miao Xu(National Center for Advancing Translational Sciences), Alexey Zakharov(National Center for Advancing Translational Sciences), Wei Zhu(National Center for Advancing Translational Sciences), Wei Zheng(National Center for Advancing Translational Sciences), Anton Simeonov(National Center for Advancing Translational Sciences), Ewy A. Mathé(National Center for Advancing Translational Sciences), Marc Ferrer(National Center for Advancing Translational Sciences), Donald C. Lo(National Center for Advancing Translational Sciences), Min Shen(National Center for Advancing Translational Sciences), Matthew D. Hall(National Center for Advancing Translational Sciences)
bioRxiv (Cold Spring Harbor Laboratory)
June 5, 2020
Cited by 108Open Access
Full Text

Abstract

The National Center for Advancing Translational Sciences (NCATS) has developed an online open science platform - named the NCATS OpenData Portal (ODP) - for quickly and freely sharing complete NCATS translational datasets via an open-access, user-friendly interface. This paper describes the establishment of the ODP, initially deployed during the COVID-19 crisis, and provides a detailed analysis of COVID-19 drug repurposing screening datasets that served as the first large-scale use case for the platform. Over 10,000 compounds were tested across 17 quantitative high-throughput assays, covering a wide spectrum of the SARS-CoV-2 life cycle. In total, over 87,000 concentration-response curves and 426,000 data points were made publicly available on ODP in near real-time, enabling immediate access to complete datasets. The resource is flexible in accommodating various types and structures of data, and it has already expanded since its launch to host additional datasets for COVID-19, other viruses of pandemic potential, and beyond. The OpenData Portal has been designed as a scalable platform for real-time data sharing across drug discovery campaigns, regardless of disease area, with the overarching goal of accelerating discovery at NCATS, the NIH, and the greater scientific community.


Related Papers

No related papers found

Powered by citation graph analysis